


























<!DOCTYPE html>
<html lang="en">
<head>
	<meta charset="utf-8" />
	<title>NIH Annual Report MH002927</title>

	<!-- <link href='https://fonts.googleapis.com/css?family=Open+Sans:400italic,400,300,600' rel='stylesheet' type='text/css'> -->


<link rel="icon" type="image/x-icon" href="../reportviews/styles/favicons/sci_search.ico" />	<link rel="stylesheet" type="text/css" media="screen" href="../reportviews/styles/searchview.css" />
	<link rel="stylesheet" type="text/css" media="print" href="../reportviews/styles/printreports.css" />

	


<!-- ajax header -->
<script type="text/javascript" src="../scripts/prototype.js"></script>

<script type="text/javascript" src="../scripts/scriptaculous.js"></script>
<script type="text/javascript" src="../scripts/showhide.js"></script>



<script language="javascript">

function runthis (targetDiv,dataSource,setForm) {	

    var handlerFunc = function(t) {
    $(targetDiv).innerHTML = t.responseText;
    }

Ajax.Responders.register({
  onCreate: function() {
  $(targetDiv+"loading").style.display = "block";
 
  },
  onComplete: function() {
   $(targetDiv+"loading").style.display = "none";
  }
})

var allNodes= Form.serialize(setForm);

var myAjax = new Ajax.Request(dataSource, {method:'post',parameters:allNodes,onComplete:handlerFunc});
}


</script>

<!-- ajax header ends -->
</head>
<body><br/><br />


<div style="font-weight: bold; text-align: center;">NIH Annual Intramural Research Report
</div>



<div id="container">
	<div id="content">
	<div class="contentlabel">MH002927-07</div>
	<div class="datacontainer">

<div class="rowdiv">
<div class="headings">
Report Title</div>
</div><div class="rowdiv">
<div class="data">Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders


</div>
</div>





<div class="rowdiv">
<div class="headings">2016 Fiscal Year</div></div>

<div class="rowdiv">
<div class="data"> October 01, 2015 -  September 30, 2016</div></div>


<style>

a  {
    text-decoration: none;
}
</style>

<!-- set up arrays -->






 <!-- ends test for any LIs -->


<div class="rowdiv">
<div class="headings">
Principal Investigator  </div></div>

<div class="rowdiv">
<div class="data">
<div class="topdiv">

<div style="float: left; width: 50%;"> <!-- faculty test -->

Carlos Alberto Zarate; MD

</div>

 <a href="https://irp.nih.gov/pi/carlos-zarate" target="_blank"><span class="irpbutton">
IRP Faculty Profile</a></span>
                        <div class="clearfix"></div> <!-- faculty test -->
</div><br />

</div>

</div>


 <!-- ends test for any pis -->


 <!-- test for any PIs or LIs -->








<div class="rowdiv">
<div class="headings">Research Organization</div>
 </div>
 <div class="rowdiv">
<div class="data">


Section on Neurobiology and Treatment of Mood Disorders, NIMH

</div>
</div>




















<div id="morelabstaff">


<!-- display description li -->





<div class="rowdiv">
<div class="headings">
Lab Staff and Collaborators within the <i>Section on Neurobiology and Treatment of Mood Disorders</i></div>


<div class="morelist">
<form id="morelabstaffu">6 of a total of 31 Lab Staff members are shown. </div>



<div class="rowdiv">
<div class="data">

 <!-- step through any ordered staff -->






Rezvan  Ameli<br />




Elizabeth Day Ballard<br />




Charles Nicholas Barker; BS<br />




Charles Ralph Bender<br />




Hannah Elizabeth Berg<br />




Nancy E Brutsche<br />

 <!-- step through any unordered staff -->
 <!-- test for 6 or more ordered labstaff -->







<a href="#" onclick="runthis('morelabstaff','searchview.taf?_function=showmore&ios=L&ipid=96300&onameset=Section on Neurobiology and Treatment of Mood Disorders&isajaxlink=Y&_UserReference=8F5EA5C36621909F5B38D1A8','morelabstaffu');  return false;">


<span class="morelist">Show all 31</span></a></form></div>



</div>
</div>
</div>

 <!-- test for display off all staff versus max of six -->
 <!-- test for any labstaff -->




	



<!-- display collaborators from the same IC -->










<div class="rowdiv">
<div class="headings">
Collaborators from other NIMH organizations</div>



<div class="rowdiv">
<div class="data">











Richard  Coppola; SB, DSc  (Magnetoencephalography Core)<br />



Masahiro  Fujita  (Section on PET Neuroimaging Sciences)<br />



Robert  Innis; MD  (Molecular Imaging Branch)<br />



Ellen  Leibenluft; MD  (Section on Mood Dysregulation and Neuroscience)<br />



Kathleen R Merikangas; PhD  (Section on Developmental Genetic Epidemiology)<br />








</div>
</div>





	














	
	<!-- display description li -->












<div class="rowdiv">
<div class="headings">
Extramural Collaborator
 </div>
 
</div>

<div class="rowdiv">
<div class="data">











Todd  Gould; MD
<i>(University of Maryland)</i>
<br />










</div>
</div>




 <!-- if showmore or just first 6 -->

 <!-- if any ex -->
	



<!-- display description li -->
<div class="rowdiv">
<div class="headings">
Keywords
 </div></div>
 <div class="rowdiv">
<div class="data">
Neurobiology, Oxidative stress, Anxious Depression, Novel Treatment, Brain circuits, Epidemiology, Bcl-2, Cytokines, glycine receptor, Depression, Major Depressive Disorder, Biomarker, suicide

</div>
</div>


<!-- goals -->


<div class="rowdiv">
<div class="headings">
Goals and Objectives
 </div></div>
 <div class="rowdiv">
<div class="data">
These projects aim to better understand the neurobiology of treatment-resistant major depressive disorder, bipolar disorder, and suicide and to identify novel therapeutic targets for depression and suicidal thinking. Moreover, the neurobiological effects of treatments and treatment response are explored under this project. In addition, we perform deep phenotyping with the data from all studies conducted in our Branch which includes genetics, neuropsychological testing, structural and brain imaging, electrophysiological studies and peripheral blood measures to identify markers of diagnosis and treatment response. Further, we study symptom and syndrome dimensions of depression (RDoC, NIMH Research Domain Criteria). Finally, we conduct proof-of-concept studies under this protocol to identify putative targets for developing novel antidepressants.<br /><br />Studies underway include:<br />1. A Pathophysiological Study to Determine if Enhancing Glutamate Transporter Function Produces Antidepressant Effects in Patients with Major Depressive Disorder <br /><br />Design: Male and female patients, ages 18 to 65 years, with a diagnosis of major depressive disorder (MDD) will be recruited. This study will consist of the double-blind crossover administration of either diazoxide (200-400 mg/day given orally) or placebo over the course of 3 weeks in improving overall depressive symptomatology in patients with treatment-resistant MDD. Other aims of the study include: 1) determining whether changes in brain neurochemicals (glutamate) correlate with antidepressant response (decrease in Montgomery-Asberg Depression Rating Scale (MADRS) total scores).<br /><br />Outcome measures: Primary: MADRS total score. <br /><br />2. An investigation of the Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder. <br /><br />Design: This study is a single-site, open-label protocol in psychotropic medication-free depressed subjects. This protocol consists of two phases (Phase I and Phase II). The first phase consists of the medication taper and drug-free period. The second phase will have three subphases: Subphase IIA (alcohol clamp infusion #1 with neurophysiological assessments), IIB alcohol clamp infusion #2 during 7 Tesla-Magnetic Resonance Spectroscopy/Imaging (7T-MRS/I) and IIC (subanesthetic/antidepressant dose ketamine infusion during 7T-MRS/I). <br /><br />Outcome Measures: The primary hypothesis/outcome measure will be change in mean MADRS total score from the pre-ketamine infusion baseline-to-7 days post-infusion between the Family History Positive or Negative groups. Other exploratory measures include neurophysiological responses to intravenous alcohol infusion, brain neurochemical alterations during intravenous alcohol infusion, and brain neurochemical alterations during intravenous ketamine infusion.<br /><br />3. An Investigation of the Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder <br /><br />Design: Male and female patients, ages 18 to 65 years, with a diagnosis of MDD, currently in an episode of major depression, will be recruited. This study will consist of the double-blind crossover administration of either AV-101 (glycine antagonist, (1,080 or 1,440 mg/day given orally) or placebo. The study will assess the efficacy of 2 weeks of a glycine antagonist compared with placebo in improving overall depressive symptomatology in patients with treatment-resistant MDD. <br />Outcome measures: Primary: Hamilton Depression Rating Scale (HDRS) total score. <br /><br />4. Neurobiology of Suicide<br />The aim of this study is to evaluate possible biomarkers of suicidal thoughts and behaviors in individuals currently experiencing a suicidal crisis.  In taking a dimensional approach to suicide research, we will be able to study phenomenology across Research Domain Criteria (RDoC) units of analysis, from genes through circuits to self-report and experimental interventions.
</div>
</div>
 <!-- allows for earlier years when this data was not collected -->
 <!-- do not even try to display before 2006 -->

<!-- summary -->
<div class="rowdiv">
<div class="headings">
Summary
 </div></div>
 
 <div class="rowdiv">
<div class="data">
This Report involves work collected under protocols 01-M-0254 (NCT00024635 ); 08-M-0196 (NCT00759395); 08-M-0150 (NCT00697268); 14-M-0085 (NCT02122562); 07-M-0021 (NCT00397111); 14-M-0041 (NCT02049385); and 07-M-0152 (NCT00472576), 09-M-N230; 15-M-0151 (NCT 02484456), 15-M-0188 (NCT02543983).<br /><br />Results this past year:<br />1.	Antisuicidal response after ketamine infusion is associated with decreased nighttime wakefulness in treatment-resistant depression. In this study, we find a biomarker that predicts who will respond to ketamine and who will not. Here we find that subjects with treatment-resistant depression who have more time awake at later times of the night have more suicidal thinking, and that a single dose of ketamine rapidly eliminates suicidal thinking and restores sleep in depressed patients. The pattern of sleep is no longer different from healthy control subjects.<br />2.	Safety of research into severe and treatment-resistant mood disorders. In this review of 12 years of data of from the intramural program at NIMH, we show that randomized, placebo-controlled drug-free trials in treatment-resistant depression can be performed safely in an inpatient setting. <br />3.	A randomized, placebo-controlled pilot trial of the delta opioid agonist AZD2327 in anxious major depressive disorder. In this double-blind, placebo-controlled pilot study, we show that the delta opioid agonist AZD2327 does not have significant antidepressant property in anxious major depressive disorder. We do find that one of its metabolites appears to have anxiolytic effects.<br />4.	The prodrug 4-chlorokynurenine causes ketamine-like antidepressant, but not side effects, by NMDA/glycineB-site inhibition. This work extends our finding of the rapid antidepressant effects of ketamine. Ketamine modulates the NMDA receptor complex; we believe that such actions are in part responsible for its significant side effects and risk of abuse. We believe  that the prodrug 4-chlorokynurenine would more selectively modulate the NMDA receptor complex and thus not result in the liabilities of ketamine (i.e., side effects, risk of abuse). In a series of animal studies we demonstrate the safety of this new compound. A clinical study has begun at the intramural program at NIMH in patients with depression. <br />5.	Reliability of 1H-MRS measured human prefrontal cortex glutamatergic signals at 7 Tesla. We demonstrate the reliability of a new technique for measuring the brain levels of glutamate, believed to be important to rapid antidepressant effects of ketamine. Such technology could help us track the changes in brain glutamate levels before and after ketamine which could help in better understanding antidepressant effects and to develop better treatments.  <br />6.	Group differences in MEG-ICA  derived  resting state networks. We demonstrate using a new technology (magnetoencephalography, MEG), differences in resting state brain networks between patients with depression and healthy controls. <br />
</div>
</div>
<div id="publications">










	

	
	

	
		
	




<!-- display pubs -->
<form></form>
<form id="publicationsu">
<div class="rowdiv">
<div class="headings">



Publications Generated during the 2016 Reporting Period<br />	

<span class="showlinknospace"><span style="font-weight: normal;font-size:0.8em;">

		



<a href="#" onclick="runthis('publications','searchview.taf?_function=bibs&ipid=96300&allpubs=Y&isajaxlink=Y&_UserReference=8F5EA5C36621909F5B38D1A8','publicationsu');  return false;">


See Project Bibliography</a></span></span>
		
	

<div id="publicationsloading" style="display: none;" class="loadingstyle">Loading Bibliography <img src="../NIDBstyles/images/ajaxgifs/blue_bar.gif" alt="Processing ..." width="43" height="11" hspace="5" vspace="0" border="0" align="bottom"></div>
</div></div>

<div class="rowdiv">

<div class="data">












<p style="font-size: 0.8em; font-style: italic;">
Ordered by publication type and then author name.
</p>













<hr />Journal articles<hr />
<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">1.</div>
<div style="margin: -1.6em 0px 5px 2em;">Ballard ED, Luckenbaugh DA, Richards EM, Walls TL, Brutsché NE, Ameli R, Niciu MJ, Vande Voort JL, Zarate CA (2015). Assessing measures of suicidal ideation in clinical trials with arapid-acting antidepressant. J Psychiatr Res  68, 68-73.

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26228403?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522045/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26228403
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4522045 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">2.</div>
<div style="margin: -1.6em 0px 5px 2em;">Furey ML, Drevets WC, Szczepanik J, Khanna A, Nugent A, Zarate CA (2015) Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine. Int J Neuropsychopharmacol 18:

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/25820840?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571629/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 25820840
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4571629 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">3.</div>
<div style="margin: -1.6em 0px 5px 2em;">Iadarola ND, Niciu MJ, Richards EM, Vande Voort JL, Ballard ED, Lundin NB, Nugent AC, Machado-Vieira R, Zarate CA (2015) Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis 6:97-114

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/25954495?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416968/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 25954495
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4416968 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">4.</div>
<div style="margin: -1.6em 0px 5px 2em;">Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA (2015) Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. J Psychopharmacol 29:596-607

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/25691504?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116382/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 25691504
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5116382 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">5.</div>
<div style="margin: -1.6em 0px 5px 2em;">Machado-Vieira R, Zanetti MV, Teixeira AL, Uno M, Valiengo LL, Soeiro-de-Souza MG, Oba-Shinjo SM, de Sousa RT, Zarate CA, Gattaz WF, Marie SK (2015) Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder. Eur Neuropsychopharmacol 25:468-73

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/25726893?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863235/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 25726893
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5863235 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">6.</div>
<div style="margin: -1.6em 0px 5px 2em;">Nugent AC, Martinez A, D'Alfonso A, Zarate CA, Theodore WH (2015) The relationship between glucose metabolism, resting-state fMRI BOLD signal, and GABAA-binding potential: a preliminary study in healthy subjects and those with temporal lobe epilepsy. J Cereb Blood Flow Metab 35:583-91

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/25564232?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420874/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 25564232
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4420874 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">7.</div>
<div style="margin: -1.6em 0px 5px 2em;">Nugent AC, Robinson SE, Coppola R, Furey ML, Zarate CA (2015) Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder. Neuroimage 118:1-12

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26032890?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555091/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26032890
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4555091 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">8.</div>
<div style="margin: -1.6em 0px 5px 2em;">Park M, Niciu MJ, Zarate CA (2015) Novel Glutamatergic Treatments for Severe Mood Disorders. Curr Behav Neurosci Rep 2:198-208

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26824031?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725605/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26824031
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4725605 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">9.</div>
<div style="margin: -1.6em 0px 5px 2em;">Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA (2015) Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders. J Psychiatr Res 68:99-105

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26228407?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522041/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26228407
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4522041 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">10.</div>
<div style="margin: -1.6em 0px 5px 2em;">Schaffer A, Isometsä ET, Azorin JM, Cassidy F, Goldstein T, Rihmer Z, Sinyor M, Tondo L, Moreno DH, Turecki G, Reis C, Kessing LV, Ha K, Weizman A, Beautrais A, Chou YH, Diazgranados N, Levitt AJ, Zarate CA, Yatham L (2015). A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry  49, 1006-20.   https://doi.org/10.1177/0004867415594428

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26175498?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858693/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26175498
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5858693 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">11.</div>
<div style="margin: -1.6em 0px 5px 2em;">Schaffer A, Isometsä ET, Tondo L, Moreno DH, Sinyor M, Kessing LV, Turecki G, Weizman A, Azorin JM, Ha K, Reis C, Cassidy F, Goldstein T, Rihmer Z, Beautrais A, Chou YH, Diazgranados N, Levitt AJ, Zarate CA, Yatham L (2015). Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry  49, 785-802.   https://doi.org/10.1177/0004867415594427

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26185269?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116383/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26185269
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5116383 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">12.</div>
<div style="margin: -1.6em 0px 5px 2em;">Teixeira AL, de Souza RT, Zanetti MV, Brunoni AR, Busatto GF, Zarate CA, Gattaz WF, Machado-Vieira R (2015) Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment. Hum Psychopharmacol 30:52-6

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/25572309?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858728/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 25572309
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 5858728 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->






<div style="margin: 0px 0px 10px 0px;">
<div style="margin: 0px 0px 5px 0px;">13.</div>
<div style="margin: -1.6em 0px 5px 2em;">Zanos P, Piantadosi SC, Wu HQ, Pribut HJ, Dell MJ, Can A, Snodgrass HR, Zarate CA, Schwarcz R, Gould TD (2015) The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition. J Pharmacol Exp Ther 355:76-85

<div class="showlink">

    










<a href="https://www.ncbi.nlm.nih.gov/pubmed/26265321?dopt=Abstract" target="_blank">PubMed</a>


        
 &nbsp;&nbsp;&nbsp;&nbsp;<!-- if linktext is empty then just the basic link is provided. Otherwise, with link text, the link is fully qualified. Opens in new page if newtab is Y. -->






<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576668/?report=classic" target="_blank">Free Article</a>


         <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div> <!-- show link -->
<br />
<div class="nolink">
PubMed ID 26265321
     &nbsp;&nbsp;&nbsp;&nbsp;Pubmed Central ID 4576668 <!-- looks for PMC ID -->
     <!-- looks for PubMed ID -->
</div><!-- no print link div -->

</div> <!-- pubstring + links -->
</div><!-- pub surround div -->


 <!-- ends unordered rows -->
 <!-- test for any unordered pubs -->

 <!-- ends test for any pubs -->

</div>

</div>
</form> <!-- ends form id publicationsu -->
 <!-- show nothing if a non-bib type of project --></div></div>
<div class="showlink">
<hr /><div style="text-align: center; font-weight: bold;"><a href="../search/index.taf">Return to Intramural Search page?</a></div>
</div>
</body></html>